Molecular profiling of bladder cancer: involvement of the TGF-beta pathway in bladder cancer progression.

Autor: Hung TT; Oncology Research Centre, Level 2, Clinical Sciences Building, Prince of Wales Hospital, Barker Street, Randwick, NSW 2031, Australia., Wang H, Kingsley EA, Risbridger GP, Russell PJ
Jazyk: angličtina
Zdroj: Cancer letters [Cancer Lett] 2008 Jun 28; Vol. 265 (1), pp. 27-38. Date of Electronic Publication: 2008 May 13.
DOI: 10.1016/j.canlet.2008.02.034
Abstrakt: A human bladder cancer model of nine cell sublines derived from the BL17/2 cell line was used to evaluate genes related to disease progression. Molecular profiling of sublines that were non-tumorigenic and invasive in nude mice was performed and identified 1367 differentially-expressed genes. Quantitative real-time PCR analysis of six transforming growth factor-beta (TGF-beta) pathway genes using the entire panel of nine cell lines was performed. Bone morphogenetic protein-2 expression was significantly associated with in vivo tumorigenicity of the cell lines (p=0.0228, Mann-Whitney); inhibin-betaB was related to their invasiveness (p=0.0468, Mann-Whitney). Analysis of conditioned medium showed TGF-beta1 production to be significantly associated with the phenotype of the cell line. The study shows the possible involvement of the TGF-beta pathway in bladder cancer progression.
Databáze: MEDLINE